October 9, 2009 Kringle Pharma Receives the Grand Prix of the 6th Japan Bio-Venture Award.
August 4, 2009 Kringle Pharma Finishes its Phase 1a Clinical Trial of Recombinant Human HGF for Treatment of Renal Disease.
January 28, 2009 Kringle Pharma and Maruho Agreed to Conclude an Option Agreement
for ChronSeal
®.
Copyright (C)2004 Kringle Pharma, Inc. All rights reserved.